Trial Profile
Open-label, Post-marketing Observational Study to Evaluate the Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms QUALISLEEP
- Sponsors Ipsen
- 04 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Dec 2014 New trial record